Literature DB >> 12007729

Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control.

Lea Sorensen1, Lynda Molyneaux, Dennis K Yue.   

Abstract

AIMS/HYPOTHESIS: To study similarities and differences between people with insensate or painful diabetic peripheral neuropathy, particularly in relation to height, gender, ethnicity and glycaemic control.
METHODS: We studied prospectively 2610 patients with Type 2 diabetes attending our Diabetes Centre. Subjects were compared according to degree of sensory loss, and presence or absence of neuropathic pain. The effects of gender and ethnicity were evaluated by studying patients in different height bands.
RESULTS: Insensate neuropathy and painful neuropathy was present in 11.4 and 3.3% of subjects, respectively. Age, duration of diabetes, height, vibration perception and HbA(1c) (P<0.0001) were independent determinants of insensate neuropathy, whereas only duration of diabetes and vibration perception (P<0.0001) were predictive of pain. There was more insensate neuropathy in males (OR 1.9) and anglo-celtics (OR 1.4) but stratification by height showed that these effects were due to height. Height has no influence on the development of pain.
CONCLUSIONS: There is significant overlap but also considerable dichotomy in the two major forms of diabetic sensory peripheral neuropathy. The insensate type is more explainable by duration, degree of hyperglycaemia and length of peripheral nerves, factors that are likely to reflect severity of underlying structural nerve damage. Glycaemic control was not a predictor of painful neuropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007729     DOI: 10.1016/s0168-8227(02)00010-4

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  27 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

2.  Peripheral insensate neuropathy-is height a risk factor?

Authors:  G S Sharath Kote; Ajay N Bhat; Thajuddeen K; Mohammed H Ismail; Abhishek Gupta
Journal:  J Clin Diagn Res       Date:  2012-12-24

Review 3.  Gender differences in diabetes-related lower extremity amputations.

Authors:  Monica E Peek
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

Review 4.  Treatment of painful diabetic neuropathy.

Authors:  Saad Javed; Ioannis N Petropoulos; Uazman Alam; Rayaz A Malik
Journal:  Ther Adv Chronic Dis       Date:  2015-01       Impact factor: 5.091

Review 5.  Diabetic painful neuropathy: current and future treatment options.

Authors:  M Sam Chong; Joan Hester
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Painful and painless diabetic neuropathy: one disease or two?

Authors:  Vincenza Spallone; Carla Greco
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

7.  Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  Pain       Date:  2008-08-30       Impact factor: 6.961

Review 8.  Effects of treatments for symptoms of painful diabetic neuropathy: systematic review.

Authors:  Man-chun Wong; Joanne W Y Chung; Thomas K S Wong
Journal:  BMJ       Date:  2007-06-11

9.  Diabetes-induced chemogenic hypoalgesia is paralleled by attenuated stimulus-induced fos expression in the spinal cord of diabetic mice.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  J Pain       Date:  2007-05-29       Impact factor: 5.820

10.  Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors.

Authors:  Jackie Elliott; Solomon Tesfaye; Nish Chaturvedi; Rajiv A Gandhi; Lynda K Stevens; Celia Emery; John H Fuller
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.